Homepage
Author:
BioStem Technologies, Inc.
Posted Date:
April 30, 2026
BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026
BioStem Technologies, Inc.
April 30, 2026
BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer
BioStem Technologies, Inc.
April 30, 2026
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
BioStem Technologies, Inc.
April 8, 2026
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
BioStem Technologies, Inc.
March 31, 2026
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
BioStem Technologies, Inc.
March 30, 2026
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
BioStem Technologies, Inc.
March 24, 2026
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
BioStem Technologies, Inc.
March 23, 2026
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
BioStem Technologies, Inc.
March 11, 2026
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
BioStem Technologies, Inc.
February 20, 2026
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
BioStem Technologies, Inc.
February 3, 2026
1
2
Next
